Corporate News

George Institute Co-Founder Nominated Among Australia’s Top Influential Women

The George Institute for Global Health’s Co-Founder and Principal Director Dr. Robyn Norton has been nominated as one of The Australian Financial Review’s 2019 top 100 Women of Influence, recognizing her leadership and trailblazing efforts in global health and gender equity. The Women of Influence Award celebrate women leaders who have pushed back against unfairness, […]

Read More

October 18th, 2019

Sean Hart Named Chief Business Officer of George Clinical

SYDNEY, October 8, 2019 – George Clinical, a global scientifically-driven clinical research organization (CRO), today announced the promotion of Sean Hart to the new role of Chief Business Officer. Hart, who joined George Clinical through the acquisition of Vector Oncology in 2017, will now lead business development functions globally for the organization. “Sean has demonstrated […]

Read More

October 8th, 2019

George Clinical Grows European Presence with New Location in the United Kingdom

LONDON, August 19, 2019 – George Clinical, a global scientifically-backed clinical research organization (CRO), has expanded its presence in Europe with the opening of a larger and more sophisticated location in the United Kingdom.  The office is based in London and compliments the organization’s growing list of global locations throughout the Asia-Pacific region, the United […]

Read More

September 17th, 2019

The George Institute and UNSW Founders Build Ecosystem for Health Innovations

In what could come as a big boost to entrepreneurs working to promote healthcare through innovations across the globe, University of New South Wales—Sydney and The George Institute for Global Health (TGI) have joined forces to launch a program dubbed Health10x designed to accelerate and scale up health focused start-ups. The Health10x program was conceived […]

Read More

September 11th, 2019

Professor Bruce Neal Appointed Executive Director of The George Institute

George Clinical is pleased to announce that Dr. Bruce Neal has been appointed Executive Director of The George Institute Australia effective September 1.   Neal was a founding member of the Institute, together with John Chalmers and Principal Directors Stephen MacMahon and Robyn Norton.  Neal has contributed to the growth of the Institute across many areas […]

Read More

September 5th, 2019

Award Highlights George Clinical as Leading Employer in Asia-Pacific Region

Last year George Clinical gained recognition by the Mandatory Provident Fund (MPF) legislation for their provision of good MPF benefits in Hong Kong.  The Mandatory Provident Fund Schemes Authority (MPFA) awarded George Clinical their Good MPF Employer Award at a ceremony in Hong Kong where Evon Hui, Head of Business Operations, East Asia, accepted the […]

Read More

July 13th, 2019

George Clinical Welcomes FDA Framework for Real World Evidence Program

December of 2018 saw the FDA release their “Framework For Evaluating the Potential Use of Real-World Evidence (RWE)” to support the approval of a new indication for a drug already approved under section 505(c) of the FD&C Act.  This document was developed to outline guidance and support of real world data collection efforts for post-approval […]

Read More

June 1st, 2019

CTTI Recommendations Developed to Improve Engagement in Mobile Clinical Trials

George Clinical is proud to have been involved in developing the recently announced recommendations by the Clinical Trial Transformation Initiative (CTTI): The Recommendations for Engaging Patients and Sites in Mobile Clinical Trials. The recommendations, to which George Clinical contributed as a member on the expert committee, aim to help research organizations, sponsors, and other stakeholders […]

Read More

June 1st, 2019

George Clinical Expands Asia-Pacific Footprint with New Location in the Philippines

SYDNEY, May 29, 2019 – George Clinical, a global scientifically-backed clinical research organization (CRO), has again expanded its extensive Asia-Pacific footprint through the opening of a new office in the Philippines.  The office is based in the capital city, Manila and compliments the organization’s growing list of global locations.   The opening of this office […]

Read More

May 29th, 2019

George Clinical Awarded Taiwanese Drug License

 SYDNEY, May 15, 2019 – George Clinical, a global scientifically-backed clinical research organization (CRO), has significantly expanded its capabilities in Taiwan having been granted a license to import drugs into the country for clinical trials on behalf of sponsors.  The development will be particularly helpful for small to mid-sized clinical trial clients who do not […]

Read More

May 14th, 2019

Join our Mailing List


Add George Clinical to your network